BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

54.80

-0.09 (-0.17%)

At close: Oct 9, 2026, 4:00 PM EDT

54.80

0.00 (0.01%)

After-hours: Oct 9, 2026, 4:15 PM EDT

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	10,607	11,417	12,527	18,162	19,234	16,220
Market Cap Growth	0.99%	-8.86%	-31.03%	-5.57%	18.57%	1.90%
Enterprise Value	13,935	10,544	12,199	18,132	19,051	16,229
Last Close Price	54.89	59.43	65.73	96.42	103.49	88.35

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	144.59	32.72	29.35	108.34	135.87	-
Forward PE	9.35	12.37	17.86	38.98	39.00	85.79
PS Ratio	3.11	3.54	4.39	7.51	9.18	8.79
PB Ratio	1.68	1.88	2.21	3.67	4.18	3.80
P/TBV Ratio	13.49	2.05	2.44	4.10	4.73	4.41
P/FCF Ratio	14.37	15.75	25.70	290.28	350.06	77.63
P/OCF Ratio	12.38	13.79	21.87	114.04	109.34	53.26
PEG Ratio	0.31	0.65	0.72	1.07	0.86	2.66

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.09	3.27	4.28	7.50	9.09	8.79
EV/EBITDA Ratio	21.60	14.59	21.38	62.49	121.62	481.22
EV/EBIT Ratio	27.89	16.20	25.73	97.60	348.42	-
EV/FCF Ratio	18.88	14.54	25.03	289.80	346.74	77.67

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.67	0.11	0.11	0.23	0.24	0.26
Debt / EBITDA Ratio	6.41	0.88	1.08	3.73	6.58	23.56
Debt / FCF Ratio	5.69	0.89	1.30	18.12	20.38	5.38
Net Debt / Equity Ratio	0.53	-0.15	-0.09	0.01	-0.04	0.03
Net Debt / EBITDA Ratio	5.16	-1.27	-0.88	0.21	-1.10	3.25
Net Debt / FCF Ratio	4.51	-1.27	-1.03	0.96	-3.12	0.52
Asset Turnover	0.36	0.44	0.41	0.37	0.34	0.31
Inventory Turnover	1.07	1.20	1.14	1.28	1.38	1.49
Quick Ratio	1.16	3.25	2.96	1.45	2.98	2.54
Current Ratio	2.39	5.21	5.33	2.51	4.67	4.16
Return on Equity (ROE)	1.18%	5.94%	8.05%	3.51%	3.19%	-1.53%
Return on Assets (ROA)	3.26%	5.58%	4.29%	1.76%	0.55%	-0.78%
Return on Invested Capital (ROIC)	3.24%	9.12%	7.35%	3.50%	1.18%	-1.74%
Return on Capital Employed (ROCE)	5.00%	9.50%	7.40%	3.30%	0.90%	-1.40%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.69%	3.06%	3.41%	0.92%	0.74%	-0.40%
FCF Yield	6.96%	6.35%	3.89%	0.34%	0.29%	1.29%
Buyback Yield / Dilution	-0.61%	-0.35%	-2.67%	-1.39%	-3.34%	4.61%

SEC Filings: 10-K · 10-Q